??1-Blockers vs 5??-Reductase Inhibitors in Benign Prostatic Hyperplasia
- 1 May 1995
- journal article
- research article
- Published by Springer Nature in Drugs & Aging
- Vol. 6 (5) , 388-396
- https://doi.org/10.2165/00002512-199506050-00005
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBritish Journal of Urology, 1994
- Terazosin in the treatment of benign prostatic hyperplasia. Terazosin Benign Prostatic Hyperplasia Study GroupArchives of Family Medicine, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- Finasteride in the Treatment of Benign Prostatic Hyperplasia. A Urodynamic EvaluationBritish Journal of Urology, 1992
- Natural history of benign prostatichyperplasia and risk of prostatectomy: The Baltimore Longitudinal Study of AgingUrology, 1991
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991
- Medical management of benign prostatic hyperplasiaUrology, 1990
- Prazosin in the Treatment of Prostatic Obstruction A Placebo‐controlled StudyBritish Journal of Urology, 1987
- The Natural History of Untreated “Prostatism”British Journal of Urology, 1981
- The Assessment of Prostatic Obstruction from Urodynamic Measurements and from Residual UrineBritish Journal of Urology, 1979